Drug Delivery

February 12, 2020

Jim Walter will take on the role of vice-president of operations for Catalent’s Oral and Specialty Delivery business.

January 27, 2020

The facility will produce parenteral products and delivery devices and is set to create 460 new jobs.

December 05, 2019

CPI has partnered with ImmunoBiology (ImmBio) for the development of a heat-stabilized formulation of a mutli-antigen vaccine candidate against Pneumococcal diseases.

November 21, 2019

Lonza and Cryoport have partnered up to strengthen Lonza’s ‘vein-to-vein’ delivery network by removing supply chain hurdles faced by developers of personalized therapeutics.

October 17, 2019

On Tuesday, Nov. 5, 2019, Karima Yadi from Becton Dickinson & Co. will present the challenges of using, and necessity for, shorter needles and integrated systems with high viscosity drugs, such as biologics, to improve the patient experience at CPhI Worldwide.

October 11, 2019

AstraZeneca received approval from FDA for Fasenra Pen, a pre-fillled auto-injector pen that allows for self-administration of its asthma biologic therapy, Fasenra (benralizumab).

September 23, 2019

FDA has approved Novo Nordisk’s Rybelsus (semaglutide), a glucagon-like peptide receptor protein treatment in oral tablet form for type 2 diabetes.

September 19, 2019

The company will supply its heparin sodium injection in prefilled syringe form.

September 16, 2019

The companies aim to integrate glucose sensing with insulin delivery technologies to help change the way diabetes is managed.

September 13, 2019

TrakCel and McKesson have formed a collaboration that is aimed at accelerating commercialization of cell and gene therapies by leveraging services to enable a more efficient development pathway.